NCT00012090View on ClinicalTrials.gov

Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2000

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG

bicalutamide

DRUG

goserelin acetate

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00012090 - Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum | Biotech Hunter | Biotech Hunter